- Home
- DMA
as 07-26-2024 4:00pm EST
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 72.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 34.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | N/A | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $4.78 - $8.00 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Destra Multi-Alternative Fund (DMA)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. | DMA | 10% Owner | Jul 16 '24 | Buy | $8.39 | 77,666 | $651,617.74 | 1,682,757 | SEC Form 4 |
| Saba Capital Management, L.P. | DMA | 10% Owner | Jul 16 '24 | Buy | $8.40 | 9,079 | $76,263.60 | 1,605,091 | SEC Form 4 |
| Saba Capital Management, L.P. | DMA | 10% Owner | Jul 11 '24 | Buy | $8.41 | 60,280 | $506,954.80 | 1,536,844 | SEC Form 4 |
| Saba Capital Management, L.P. | DMA | 10% Owner | Jul 11 '24 | Buy | $8.40 | 99,569 | $836,379.60 | 1,476,564 | SEC Form 4 |
| Saba Capital Management, L.P. | DMA | 10% Owner | Jul 3 '24 | Buy | $8.00 | 43,268 | $346,144.00 | 1,315,744 | SEC Form 4 |
| Saba Capital Management, L.P. | DMA | 10% Owner | Jul 3 '24 | Buy | $7.98 | 100 | $798.00 | 1,272,476 | SEC Form 4 |
| Saba Capital Management, L.P. | DMA | 10% Owner | Jun 25 '24 | Buy | $7.74 | 40,737 | $315,304.38 | 1,263,619 | SEC Form 4 |
| Saba Capital Management, L.P. | DMA | 10% Owner | Jun 24 '24 | Buy | $7.54 | 9,881 | $74,502.74 | 1,222,882 | SEC Form 4 |
| Saba Capital Management, L.P. | DMA | 10% Owner | Jan 23 '24 | Buy | $6.65 | 8,447 | $56,172.55 | 1,213,001 | SEC Form 4 |
| Saba Capital Management, L.P. | DMA | 10% Owner | Jan 18 '24 | Buy | $6.46 | 23,957 | $154,762.22 | 1,204,554 | SEC Form 4 |
| Saba Capital Management, L.P. | DMA | 10% Owner | Jan 16 '24 | Buy | $6.46 | 10,053 | $64,942.38 | 1,170,544 | SEC Form 4 |
| Saba Capital Management, L.P. | DMA | 10% Owner | Jan 10 '24 | Buy | $6.35 | 44,824 | $284,632.40 | 1,170,544 | SEC Form 4 |
Latest Destra Multi-Alternative Fund News
DMA Breaking Stock News: Dive into DMA Ticker-Specific Updates for Smart Investing
Insider Monkey
6 months ago
Bank7 Corp. (NASDAQ:BSVN) Q4 2023 Earnings Call Transcript
Simply Wall St.
6 months ago
TPI Composites, Inc. (NASDAQ:TPIC): Are Analysts Optimistic?
StockStory
6 months ago
Apparel Retailer Stocks Q3 Recap: Benchmarking Victoria's Secret (NYSE:VSCO)
GuruFocus.com
6 months ago
Chuck Royce Increases Stake in PowerFleet Inc
Business Wire
6 months ago
The Container Store Selects American Heart Association as National Nonprofit Partner for 2024
GlobeNewswire
6 months ago
Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts
StockStory
6 months ago
Unpacking Q3 Earnings: Tilly's (NYSE:TLYS) In The Context Of Other Apparel Retailer Stocks
GlobeNewswire
6 months ago
Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement
Compare DMA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DMA Destra Multi-Alternative Fund - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.